{"id":18544,"date":"2023-01-10T12:05:20","date_gmt":"2023-01-10T12:05:20","guid":{"rendered":"https:\/\/clinlabint.com\/?p=18544"},"modified":"2023-01-10T12:05:20","modified_gmt":"2023-01-10T12:05:20","slug":"astrea-bioseparations-acquires-delta-precision-ltd-a-leading-manufacturer-of-chromatography-columns-for-biomanufacturing","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/astrea-bioseparations-acquires-delta-precision-ltd-a-leading-manufacturer-of-chromatography-columns-for-biomanufacturing\/","title":{"rendered":"Astrea Bioseparations acquires Delta Precision Ltd, a leading manufacturer of chromatography columns for biomanufacturing"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Astrea Bioseparations acquires Delta Precision Ltd, a leading manufacturer of chromatography columns for biomanufacturing<\/h1>\/ in E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n
\"\"<\/div><\/div><\/div>
\n

Astrea Bioseparations (\u201cAstrea Bio\u201d), a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd. (\u201cDelta Precision\u201d), a premier manufacturer of advanced chromatography columns for the biotechnology and pharmaceutical industries.<\/h3>\n

<\/p>\n

This strategic acquisition, which follows a long-standing relationship of almost a decade, will allow Astrea Bio to expand its product offering to include a full range of high-performance chromatography columns for biomanufacturing, complementing and strengthening the company\u2019s existing portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns. Delta Precision\u2019s products are widely recognized for their quality, ease of use, and durability, and are used in a variety of applications, including protein purification, vaccine production, and drug development.<\/p>\n

\u201cWe are delighted to welcome the Delta team into the fold. The acquisition of Delta is another step forward in Astrea Bio\u2019s rapid expansion to support the biopharmaceutical manufacturing field<\/em>,\u201d said Terry Pizzie, CEO of Astrea Bio.<\/strong> \u201cThis is a highly strategic move for us, allowing us to offer a full range of industry-leading purification and separation tools.<\/em>\u201d<\/p>\n<\/div><\/section>
\n

\"\"<\/div><\/div><\/div>
\n

Geoff Parnell, Co-founder and Managing Director at Delta Precision, remarked,<\/strong> \u201cWe look forward to joining the Astrea Bio family, further cementing the long-standing relationship between the two companies. We are confident that our expertise in column manufacturing will complement and accelerate the Astrea Bio business and customer reach<\/em>.\u201d<\/p>\n

This acquisition marks a significant milestone for Astrea Bioseparations and will allow the company to further accelerate new product development and rapidly bring new advances in purification and separation technology to market.<\/p>\n<\/div><\/section>
\n